News | Health & Safety
28 Mar 2017 13:24
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     27 Mar: NZ shares fall on Trump healthcare failure
     27 Mar: Hospital faulted for cancer patient's care
     24 Mar: Authorities warn of Auckland measles scare
     22 Mar: Spend on housing to prevent falls: study
     20 Mar: Medsafe probes use of Primodos in NZ
     19 Mar: Rural health pressure risks economy: RHA
     16 Mar: Too many kids given antibiotics by five
     Top Stories

    RUGBY RUGBY
    Force set for Super Rugby axe: report More...


    BUSINESS BUSINESS
    Insurers count cost of Kaikoura quake More...



     Today's News

    Entertainment:
    Kate Bosworth, Sarah Wayne Callies and Jason Ritter are set to star in 'Long Road Home' 13:12

    Technology:
    Dotcom ordered to back pay lost wages 13:07

    Law and Order:
    Atiamuri murder: guilty verdict 12:57

    Entertainment:
    James Corden did the whole 'It Only Takes a Minute' dance when he met Mark Owen 12:42

    Basketball:
    Breakers retain Tall Blacks centre Loe 12:27

    Entertainment:
    Doctors have had to put cocaine up Jodie Marsh's dad's nose as part of an operation 12:12

    Accident and Emergency:
    One dead in Reefton chopper crash 12:07

    Living & Travel:
    India v Australia: Furious Steve Smith appears to call Murali Vijay a cheat as series loss looms 11:57

    Entertainment:
    Katie Price found herself crushed under her wardrobe as she made her YouTube debut on Friday (24.03.17) 11:42

    Entertainment:
    Selena Gomez surprised a set of students taking part in an after school event to empower young women 11:12


     News Search






    Power Search


    © 2017 New Zealand City Ltd